BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30529266)

  • 1. Cleavage of arrestin-3 by caspases attenuates cell death by precluding arrestin-dependent JNK activation.
    Kook S; Vishnivetskiy SA; Gurevich VV; Gurevich EV
    Cell Signal; 2019 Feb; 54():161-169. PubMed ID: 30529266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
    Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
    J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.
    Breitman M; Kook S; Gimenez LE; Lizama BN; Palazzo MC; Gurevich EV; Gurevich VV
    J Biol Chem; 2012 Jun; 287(23):19653-64. PubMed ID: 22523077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death.
    Kook S; Zhan X; Cleghorn WM; Benovic JL; Gurevich VV; Gurevich EV
    Cell Death Differ; 2014 Jan; 21(1):172-84. PubMed ID: 24141717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinases.
    Zhan X; Kaoud TS; Kook S; Dalby KN; Gurevich VV
    J Biol Chem; 2013 Oct; 288(40):28535-47. PubMed ID: 23960075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
    Guo C; Whitmarsh AJ
    J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrestin-dependent activation of JNK family kinases.
    Zhan X; Kook S; Gurevich EV; Gurevich VV
    Handb Exp Pharmacol; 2014; 219():259-80. PubMed ID: 24292834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does arrestin assemble MAPKs into a signaling complex?
    Song X; Coffa S; Fu H; Gurevich VV
    J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).
    Zhan X; Kaoud TS; Dalby KN; Gurevich EV; Gurevich VV
    Curr Protoc; 2023 Sep; 3(9):e839. PubMed ID: 37668419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
    Seo J; Tsakem EL; Breitman M; Gurevich VV
    J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
    Willoughby EA; Collins MK
    J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
    Perry-Hauser NA; Kaoud TS; Stoy H; Zhan X; Chen Q; Dalby KN; Iverson TM; Gurevich VV; Gurevich EV
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis.
    Zhang Z; Hao J; Zhao Z; Ben P; Fang F; Shi L; Gao Y; Liu J; Wen C; Luo L; Yin Z
    Cell Signal; 2009 Jul; 21(7):1195-206. PubMed ID: 19306926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrestins in apoptosis.
    Kook S; Gurevich VV; Gurevich EV
    Handb Exp Pharmacol; 2014; 219():309-39. PubMed ID: 24292837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis.
    Kim SD; Moon CK; Eun SY; Ryu PD; Jo SA
    Biochem Biophys Res Commun; 2005 Mar; 328(1):326-34. PubMed ID: 15670787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex.
    Zhan X; Kaoud TS; Dalby KN; Gurevich VV
    Biochemistry; 2011 Dec; 50(48):10520-9. PubMed ID: 22047447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daxx deletion mutant (amino acids 501-625)-induced apoptosis occurs through the JNK/p38-Bax-dependent mitochondrial pathway.
    Song JJ; Lee YJ
    J Cell Biochem; 2004 Aug; 92(6):1257-70. PubMed ID: 15258908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells.
    Dyari HRE; Rawling T; Chen Y; Sudarmana W; Bourget K; Dwyer JM; Allison SE; Murray M
    FASEB J; 2017 Dec; 31(12):5246-5257. PubMed ID: 28798154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.